Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05177042 |
| Title | Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Arvinas Androgen Receptor, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR | FRA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Clinical Trial Site | Santa Monica | California | 91361 | United States | Details | |
| Clinical Trial Site | New Haven | Connecticut | 06519 | United States | Details | |
| Clinical Trial Site | Fort Myers | Florida | 33916 | United States | Details | |
| Clinical Trial Site | Boston | Massachusetts | 02114 | United States | Details | |
| Clinical Trial Site | Columbus | Ohio | 43210 | United States | Details | |
| Clinical Trial Site | Portland | Oregon | 97239 | United States | Details | |
| Clinical Trial Site | Myrtle Beach | South Carolina | 29572 | United States | Details | |
| Clinical Trial Site | Nashville | Tennessee | 37203 | United States | Details | |
| Clinical Trial Site | Charlottesville | Virginia | 22903 | United States | Details | |
| Clinical Trial Site | Vancouver | British Columbia | Canada | Details | ||
| Clinical Trial Site | Toronto | Ontario | Canada | Details | ||
| Clinical Trial Site | Montreal | Quebec | Canada | Details | ||
| Clinical Trial Site | Caen | France | Details | |||
| Clinical Trial Site | Paris | France | Details | |||
| Clinical Trial Site | Villejuif | France | Details | |||
| Clinical Trial Site | London | England | United Kingdom | Details | ||
| Clinical Trial Site | Cardiff | Wales | United Kingdom | Details | ||
| Clinical Trial Site | Preston | PR2 9HT | United Kingdom | Details |